REVEAL Trial
Study / Research
A large clinical trial testing Anacetrapib, which showed a modest reduction in events but prompted discontinuation due to drug accumulation in adipose tissue.
Mentioned in 2 videos
Save the 2 videos on REVEAL Trial to your own pod.
Sign up free to keep building your knowledge base on REVEAL Trial as more episodes are added.
Videos Mentioning REVEAL Trial
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Peter Attia MD
A large clinical trial testing Anacetrapib, which showed a modest reduction in events but prompted discontinuation due to drug accumulation in adipose tissue.
407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more
Peter Attia MD
A large outcome study by Merck with a CETP inhibitor, which demonstrated that LDL lowering with CETP inhibition can translate into cardiovascular benefit, though the drug itself was not commercialized.